PremiumCompany AnnouncementsArovella Therapeutics to Quote 750,000 New Securities on ASX Arovella Therapeutics Issues New Shares in Strategic Move Arovella Therapeutics Announces Cessation of Securities PremiumCompany AnnouncementsArovella Secures Exclusive Option to Enhance iNKT Cell Platform Arovella Therapeutics Hosts Investor Webinar to Discuss Future Plans Arovella Therapeutics Announces Investor Webinar to Discuss Strategic Progress PremiumCompany AnnouncementsArovella Therapeutics Announces Cessation of Securities Arovella Therapeutics Seeks Quotation for May Options to Boost Market Activity Arovella Therapeutics Announces Proposed Securities Issue